Mexico:
Recent Decision Of Unfair Competition In The Gray Market For Medicines In Mexico.
To print this article, all you need is to be registered or login on Mondaq.com.
Following our newsletter dated on June 25 2021, related with
increment of gray market of medicines in Mexico. In many of those
cases, importers and distributors alleged a non-direct use of the
trademarks, mentioning that the products were requested directly by
patients and/or the insurance companies. We would like to share
that OLIVARES obtained a decision at the first stage, where the
enforcing Authority declared trademark infringement, disregarding
defenses based on non-trademark use. The decision concludes that
when the accumulation and the evaluation of evidence as a whole,
show active and improper participation of the accused infringer in
the circulation of these products in the Mexican drug market. This
decision may be appealed by defendant, but it represents a good
precedent to reduce and avoidcontest unfair competition on the gray
market of medicines in Mexico.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from Mexico
Update On Divisional Applications In Mexico
OLIVARES
Divisional practice is important for almost any company interested in obtaining patent protection in certain regions. In Mexico, divisional applications have been filed throughout the years...
Requirements For Obtaining A Patent
Leão Advogados Associados
A patent is a technical document with legal purposes. Technical because it must describe an industrial creation and legal because it defines...
Patents Comparative Guide
Basham, Ringe y Correa, S.C.
Patents Comparative Guide for the jurisdiction of Mexico, check out our comparative guides section to compare across multiple countries
Mexico Patent Litigation 2024
OLIVARES
Patent litigation in Mexico is taken before the Mexican Institute of Industrial Property (in the foregoing IMPI). IMPI has enough authority for ruling on infringement...